PuSH - Publikationsserver des Helmholtz Zentrums München

Brinkmann, F.* ; Friedrichs, A.* ; Behrens, G.M.* ; Behrens, P.* ; Berner, R.* ; Caliebe, A.* ; Denkinger, C.M.* ; Giesbrecht, K.* ; Gussew, A.* ; Hoffmann, A.T.* ; Hojenski, L.* ; Hovardovska, O.* ; Dopfer-Jablonka, A.* ; Kaasch, A.J.* ; Kobbe, R.* ; Kraus, M. ; Lindner, A.* ; Maier, C.* ; Mitrov, L.* ; Nauck, M.* ; de Miranda, S.N.* ; Scherer, M.* ; Schmiedel, Y.* ; Stahl, D.* ; Timmesfeld, N.* ; Toepfner, N.* ; Vehreschild, J.* ; Wohlgemuth, W.A.* ; Petersmann, A.* ; Vehreschild, M.J.G.T.*

Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany - A cross sectional study from the German Network University Medicine (NUM).

J. Infect. Public Health 17, 642-649 (2024)
Verlagsversion DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
BACKGROUND: Vulnerability to infectious diseases in refugees is dependent on country of origin, flight routes, and conditions. Information on specific medical needs of different groups of refugees is lacking. We assessed the prevalence of infectious diseases, immunity to vaccine-preventable diseases, and chronic medical conditions in children, adolescents, and adult refugees from Ukraine who arrived in Germany in 2022. METHODS: Using different media, we recruited Ukrainian refugees at 13 sites between 9-12/2022. An antigen test for acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, serologies for a range of vaccine-preventable diseases, as well as interferon gamma release assays (IGRAs) for tuberculosis (TB), and SARS-CoV-2 were performed. We assessed personal and family history of chronic medical conditions, infectious diseases, vaccination status, and conditions during migration. RESULTS: Overall, 1793 refugees (1401 adults and 392 children/adolescents) were included. Most participants were females (n = 1307; 72·3%) and from Eastern or Southern Ukraine. TB IGRA was positive in 13% (n = 184) of the adults and in 2% (n = 7) of the children. Serology-based immunological response was insufficient in approximately 21% (360/1793) of the participants for measles, 32% (572/1793) for diphtheria, and 74% (1289/1793) for hepatitis B. CONCLUSIONS: We show evidence of low serological response to vaccine-preventable infections and increased LTBI prevalence in Ukrainian refugees. These findings should be integrated into guidelines for screening and treatment of infectious diseases in migrants and refugees in Germany and Europe. Furthermore, low immunity for vaccine-preventable diseases in Ukrainians independent of their refugee status, calls for tailor-made communication efforts.
Impact Factor
Scopus SNIP
Altmetric
4.700
1.501
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Infections ; Infectious Diseases ; Severe Acute Respiratory Syndrome Coronavirus-2 ; Ukraine ; Refugees
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 1876-0341
e-ISSN 1876-035X
Quellenangaben Band: 17, Heft: 4, Seiten: 642-649 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort 84 Theobalds Rd, London Wc1x 8rr, England
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology (EPI)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-504091-004
Förderungen German Federal Ministry of Education and Research (BMBF) Network of University
Scopus ID 85187187901
PubMed ID 38458134
Erfassungsdatum 2024-04-12